Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 1
2007 1
2008 1
2009 2
2010 3
2011 1
2012 1
2024 1
2026 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

9 results

Results by year

Filters applied: . Clear all
Your search was processed without automatic term mapping because it retrieved zero results.
Page 1
Olaparib in recurrent isocitrate dehydrogenase mutant high-grade glioma: A phase 2 multicenter study of the POLA Network.
Esparragosa Vazquez I, Sanson M, Chinot OL, Fontanilles M, Rivoirard R, Thomas-Maisonneuve L, Cartalat S, Tabouret E, Appay R, Bonneville-Levard A, Darlix A, Meyronet D, Barritault M, Gueyffier F, Remontet L, Maucort-Boulch D, Honnorat J, Dehais C, Ducray F; POLA Network. Esparragosa Vazquez I, et al. Neurooncol Adv. 2024 May 27;6(1):vdae078. doi: 10.1093/noajnl/vdae078. eCollection 2024 Jan-Dec. Neurooncol Adv. 2024. PMID: 38855053 Free PMC article.
Assessment and proposal of a new combination of screening criteria for hepatitis C in France.
King LA, Le Strat Y, Meffre C, Delarocque-Astagneau E, Desenclos JC. King LA, et al. Eur J Public Health. 2009 Oct;19(5):527-33. doi: 10.1093/eurpub/ckp112. Epub 2009 Aug 10. Eur J Public Health. 2009. PMID: 19667051
METHODS: We constructed two multiple-regression models predicting hepatitis C antibody seropositivity using the population sample from the 2004 French national hepatitis C antibody seroprevalence survey (SPS) (n = 14 416): one representing current screening guidelin …
METHODS: We constructed two multiple-regression models predicting hepatitis C antibody seropositivity using the population sample fro …
Factors associated with hospital mortality in community-acquired legionellosis in France.
Chidiac C, Che D, Pires-Cronenberger S, Jarraud S, Campèse C, Bissery A, Weinbreck P, Brun-Buisson C, Sollet JP, Ecochard R, Desenclos JC, Etienne J, Vanhems P; French Legionnaires’ Disease Study Group. Chidiac C, et al. Eur Respir J. 2012 Apr;39(4):963-70. doi: 10.1183/09031936.00076911. Epub 2011 Oct 17. Eur Respir J. 2012. PMID: 22005914 Free article.
Six predictors of death were identified by multivariate analysis: age (per 10-yr increment) (relative hazard (RH) 1.50, 95% CI 1.21-1.87), female sex (RH 2.00, 95% CI 1.08-3.69), ICU admission (RH 3.31, 95% CI 1.67-6.56), renal failure (RH 2.73, 95% CI 1.42-5.27), corticosteroid …
Six predictors of death were identified by multivariate analysis: age (per 10-yr increment) (relative hazard (RH) 1.50, 95% CI 1.21-1.87), f …
Prevalence of hepatitis B and hepatitis C virus infections in France in 2004: social factors are important predictors after adjusting for known risk factors.
Meffre C, Le Strat Y, Delarocque-Astagneau E, Dubois F, Antona D, Lemasson JM, Warszawski J, Steinmetz J, Coste D, Meyer JF, Leiser S, Giordanella JP, Gueguen R, Desenclos JC. Meffre C, et al. J Med Virol. 2010 Apr;82(4):546-55. doi: 10.1002/jmv.21734. J Med Virol. 2010. PMID: 20166185
To monitor the prevalence of hepatitis B and hepatitis C a cross-sectional survey was conducted in 2004 among French metropolitan residents. ...Anti-HCV prevalence was close to the 1990s estimates whereas HBsAg prevalence estimate was greater than expected. Screening of he …
To monitor the prevalence of hepatitis B and hepatitis C a cross-sectional survey was conducted in 2004 among French metropolitan res …
The impact of the prevention programme of hepatitis C over more than a decade: the French experience.
Delarocque-Astagneau E, Meffre C, Dubois F, Pioche C, Le Strat Y, Roudot-Thoraval F, Hillon P, Silvain C, Dhumeaux D, Desenclos JC; Hepatitis C Surveillance System Committee; Scientific Committee for the National Prevalence Survey of Hepatitis B and C Markers. Delarocque-Astagneau E, et al. J Viral Hepat. 2010 Jun;17(6):435-43. doi: 10.1111/j.1365-2893.2009.01196.x. Epub 2009 Sep 23. J Viral Hepat. 2010. PMID: 19780936
To assess the impact of the French national hepatitis C prevention programme initiated in 1999, we analysed trends in hepatitis C virus (HCV) prevalence, testing and characteristics of HCV-infected patient at first referral from 1994 to 2006. ...
To assess the impact of the French national hepatitis C prevention programme initiated in 1999, we analysed trends in hepatitis C …
Medical practices regarding hepatitis C virus infection in Europe.
Nalpas B, Delaroques-Astagneau E, Bihan CL, Drucker J, Desenclos JC. Nalpas B, et al. J Viral Hepat. 1998 Mar;5(2):131-41. doi: 10.1046/j.1365-2893.1998.00093.x. J Viral Hepat. 1998. PMID: 9572038
Six hundred and ninety-three European Association for the Study of the Liver (EASL) members, belonging to one of the 15 European Union (EU) member-states, were surveyed, through a standardized 45-item questionnaire, on their medical practices regarding hepatitis C virus (H …
Six hundred and ninety-three European Association for the Study of the Liver (EASL) members, belonging to one of the 15 European Union (EU) …
Hepatitis C virus genotype 3 and the risk of severe liver disease in a large population of drug users in France.
Larsen C, Bousquet V, Delarocque-Astagneau E, Pioche C, Roudot-Thoraval F; HCV Surveillance Steering Committee; HCV Surveillance Group; Desenclos JC. Larsen C, et al. J Med Virol. 2010 Oct;82(10):1647-54. doi: 10.1002/jmv.21850. J Med Virol. 2010. PMID: 20827760
Although risk factors for cirrhosis in chronic hepatitis C virus (HCV) infection have been identified, the role of HCV-genotype 3 remains controversial, and limited data are available in drug users. ...
Although risk factors for cirrhosis in chronic hepatitis C virus (HCV) infection have been identified, the role of HCV-genotype 3 rem …
Management of hepatitis C by European hepatologists.
Nalpas B, Desenclos JC, Delaroque-Astagneau E, Drucker J. Nalpas B, et al. J Hepatol. 1999;31 Suppl 1:141-5. doi: 10.1016/s0168-8278(99)80391-2. J Hepatol. 1999. PMID: 10622577
In 1996, the French Reseau National de Sante Publique was funded by the Direction General V of the EU to perform a European survey on the epidemiology, the surveillance, the prevention and the management of hepatitis C virus (HCV) infection in the EU member states. This st …
In 1996, the French Reseau National de Sante Publique was funded by the Direction General V of the EU to perform a European survey on the ep …